Does Plasminogen Activator Inhibitor-1 Drive Lymphangiogenesis?

The purpose of this study is to explore the function of plasminogen activator inhibitor-1 (PAI-1) during pathological lymphangiogenesis. PAI-1, the main physiological inhibitor of plasminogen activators is involved in pathological angiogenesis at least by controlling extracellular proteolysis and by...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruyère, Françoise, Melen-Lamalle, Laurence, Blacher, Silvia, Detry, Benoît, Masset, Anne, Lecomte, Julie, Lambert, Vincent, Maillard, Catherine, Høyer-Hansen, Gunilla, Lund, Leif R., Foidart, Jean-Michel, Noël, Agnès
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2836381/
https://www.ncbi.nlm.nih.gov/pubmed/20300183
http://dx.doi.org/10.1371/journal.pone.0009653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2836381/
https://www.ncbi.nlm.nih.gov/pubmed/20300183
http://dx.doi.org/10.1371/journal.pone.0009653

Ejemplares similares